Orchard Therapeutics - U.S.
@orchard_tx
Followers
2K
Following
91
Media
360
Statuses
464
Dedicated to transforming the lives of patients with inherited diseases through innovative gene therapy.
Joined January 2017
At Orchard, diversity is key to our strength and vibrancy, which is why inclusion and allyship are not confined to one day, week or month. #OrchardProud
0
0
0
Tomorrow is International Neonatal Screening Day. We stand with like-minded organizations dedicated to advancing #NewbornScreening for treatable genetic diseases. Learn more:
0
0
1
Today is #MPSAwarenessDay. We join with the community to shine a light on this group of rare, life-limiting, inherited genetic diseases. Learn more at:
0
0
1
We are honored to recognize and celebrate #RareDiseaseDay with the more than 300 million people worldwide living with a rare disease. Learn more about how to get involved: #RareDiseaseDay #ShowYourRare #EndTheDiagnosticOdyssey #SupportRareDiseases
0
0
2
We look forward to participating in the @RSTMH event “Unveiling Gene Therapy: Transforming medical practice through ATMPs.” Learn more:
0
0
2
We are excited to join the leukodystrophy community in taking strides to support @ELAOfficielle ‘Met tes baskets’ (wear your trainers) at work international challenge! Learn more at:
0
0
1
Today is #MPSAwarenessDay. We join with the community to shine a light on this group of rare, life-limiting, inherited genetic diseases. Learn more at:
0
1
1
We are incredibly proud our fearless leader, Dr. @bobby_gaspar, has been named to the inaugural 2024 #TIME100HEALTH list. Please read our press release for more information: and see the full list of honorees here:
1
0
4
Today we outlined our U.S. launch plans for Lenmeldy™ (atidarsagene autotemcel), the only approved therapy for eligible children with early-onset metachromatic leukodystrophy. Read more:
1
1
3
We are thrilled to announce that the @US_FDA has approved Lenmeldy™ (atidarsagene autotemcel), the only therapy for eligible children with early-onset metachromatic leukodystrophy in the U.S. Read more in our press release:
1
8
12
On #RareDiseaseDay please join us in helping raise awareness and #ShowYourColours in support of the millions of people living with rare diseases. Learn more at
0
0
4
We look forward to participating in @WORLDSymposia 2024 and hosting a symposia featuring expert speakers sharing their knowledge and experience to establish new standards and advance #newbornscreening through interdisciplinary collaboration. Learn more:
0
0
3
We are pleased to share that Kyowa Kirin has successfully completed the previously announced acquisition of Orchard Therapeutics. Learn more:
0
0
3
Earlier this month, we hosted the 4th MLD NBS Alliance Summit in Vienna which brought together experts and advocates with deep experience across the diagnostic journey and care continuum to advance our efforts to ensure widespread newborn screening for this devastating disease.
0
2
3
Today is World Sanfilippo Awareness Day. Join us in spreading awareness about this rare and life-limiting neurometabolic disease. Visit @CureSanfilippoF for more information: #WorldSanfilippoDay
0
0
0
We look forward to joining @RareDiseases at this week’s #NORDSummit where our Chief Medical Officer Leslie Meltzer, Ph.D., will participate in a panel on opportunities in cell and gene therapy. Learn more:
0
0
3
We are excited to announce that Kyowa Kirin and Orchard Therapeutics announced that our companies have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics. Read more:
0
1
5